Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-14

Clinical Trial Update: Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for mesenchymal stem cell-derived exosomes in anti-aging applications across Phase 1 and Phase 2, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal Stem Cell-Derived Exosomes

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Anti Aging | Phase 1, Phase 2 | Status: UNKNOWN